Miriam I. Traumann

Frankfurt Am Main, HE, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Temporal trends and sociodemographic determinants of time to nephrectomy in localized renal cell cancer.

Temporal trends and sociodemographic determinants of time to nephrectomy in localized renal cell cancer.

Journal: International urology and nephrology

Published: May 20, 2026

Type 2 Diabetes Mellitus and Adverse In-Hospital Outcomes after Nephroureterectomy.

Type 2 Diabetes Mellitus and Adverse In-Hospital Outcomes after Nephroureterectomy.

Journal: Urologia internationalis

Published: May 11, 2026

Prognostic impact of adjacent organ invasion on cancer-specific mortality in non-metastatic renal cell carcinoma.

Prognostic impact of adjacent organ invasion on cancer-specific mortality in non-metastatic renal cell carcinoma.

Journal: World journal of surgical oncology

Published: March 24, 2026

Rates and Predictors of Persistent LUTS Medication Use After Laser Enucleation of the Prostate.

Rates and Predictors of Persistent LUTS Medication Use After Laser Enucleation of the Prostate.

Journal: Lower urinary tract symptoms

Published: March 02, 2026

Survival Differences of Localized Papillary Renal Cell Carcinoma in African Americans vs. European Americans.

Survival Differences of Localized Papillary Renal Cell Carcinoma in African Americans vs. European Americans.

Journal: Journal of racial and ethnic health disparities

Published: January 26, 2026

Thulium fiber laser versus Holmium laser enucleation of the prostate: 24-month outcomes from a prospective randomized non-inferiority trial.

Thulium fiber laser versus Holmium laser enucleation of the prostate: 24-month outcomes from a prospective randomized non-inferiority trial.

Journal: World journal of urology

Published: December 15, 2025

Lower urinary tract symptoms after laser enucleation of the prostate in patients with and without preoperative indwelling catheter.

Lower urinary tract symptoms after laser enucleation of the prostate in patients with and without preoperative indwelling catheter.

Journal: International urology and nephrology

Published: October 31, 2025

Robotic vs. open partial cytoreductive nephrectomy in metastatic renal cell carcinoma: adverse in-hospital outcomes.

Robotic vs. open partial cytoreductive nephrectomy in metastatic renal cell carcinoma: adverse in-hospital outcomes.

Journal: World journal of urology

Published: May 31, 2025

The association between the interval from biopsy to radical prostatectomy and biochemical recurrence in patients with intermediate- and high-risk prostate cancer.

The association between the interval from biopsy to radical prostatectomy and biochemical recurrence in patients with intermediate- and high-risk prostate cancer.

Journal: Frontiers in oncology

Published: November 24, 2024

Androgen receptor pathway inhibitors vs. docetaxel chemotherapy for metastatic hormone-sensitive and first-line castration resistant prostate cancer.

Androgen receptor pathway inhibitors vs. docetaxel chemotherapy for metastatic hormone-sensitive and first-line castration resistant prostate cancer.

Journal: World journal of urology

Published: October 10, 2024

Administration and cancer-control outcomes of bone-modifying agents in real-world patients with metastatic castration-resistant prostate cancer.

Administration and cancer-control outcomes of bone-modifying agents in real-world patients with metastatic castration-resistant prostate cancer.

Journal: JBMR plus

Published: September 26, 2024

Influence of metastatic sites and burden on oncological outcomes in patients progressing to metastatic castration resistant prostate cancer.

Influence of metastatic sites and burden on oncological outcomes in patients progressing to metastatic castration resistant prostate cancer.

Journal: World journal of urology

Published: August 18, 2024

Showing 1-12 of 22

Last Updated: 09/26/2026